To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene TIA1andC2orf42TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
642 representative clones for gene TIA1andC2orf42 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BM835774 stomach .a 1 to 664 1 to 664   tiling clone,   664/664
(100 %)
0 diff
(100 %id)
DA771325 brain .a 29 to 592 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DB163212 thymus .a 29 to 619 2 to 592   capped   591/591
(100 %)
0 diff
(100 %id)
BG720651 testis .a 33 to 634 1 to 603       603/603
(100 %)
7 diff
(98.9 %id)
DA167351 amygdala .a 39 to 508 2 to 472   capped   471/472
(99 %)
3 diff
(99.4 %id)
DA087910 cerebellum .a 45 to 607 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA772271 brain .a 45 to 513 2 to 470   capped   469/469
(100 %)
0 diff
(100 %id)
DA941281 Spleen .a 47 to 640 2 to 596   capped   595/595
(100 %)
1 diff
(99.9 %id)
DB018846 esophageal, tumor tissue .a 47 to 594 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
DB043035 testis .a 47 to 616 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DB274570 uterus .a 50 to 609 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
DA479020   .a 52 to 625 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
AK000565   .a 53 to 2574 1 to 2522 exact tiling clone, available from FLJ, AAA   2522/2522
(100 %)
0 diff
(100 %id)
BP274028   .a 53 to 603 1 to 551       551/551
(100 %)
2 diff
(99.7 %id)
NM_017880.1   .a 53 to 2574 1 to 2522 exact RefSeq, AAA   2522/2522
(100 %)
0 diff
(100 %id)
DB257626 uterus .a 53 to 625 2 to 575   capped   574/574
(100 %)
4 diff
(99.4 %id)
DA155683 amygdala .a 54 to 625 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
DA167303 amygdala .a 54 to 617 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA201331 brain .a 54 to 590 2 to 538   capped   537/537
(100 %)
1 diff
(99.9 %id)
DA507190 brain .a 54 to 611 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DA699435   .a 54 to 575 2 to 523   capped   522/525
(99 %)
1 diff
(99.9 %id)
DA769739 brain .a 54 to 632 2 to 580   capped   579/579
(100 %)
1 diff
(99.9 %id)
DB196058 trachea .a 54 to 596 2 to 544   capped   543/543
(100 %)
1 diff
(99.9 %id)
DB203030 trachea .a 60 to 619 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
DA584398 lung .a 62 to 638 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
DB193201 ovary, tumor tissue .a 62 to 619 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
BC002825 Placenta, choriocarcinoma .a 64 to 2574 1 to 2511 exact available from MGC, AAA   2511/2511
(100 %)
1 diff
(100.0 %id)
BC005079 Skin, melanotic melanoma. .a 64 to 2574 1 to 2511   available from MGC, AAA   2511/2511
(100 %)
1 diff
(100.0 %id)
BM835497 stomach .a 64 to 655 1 to 592       592/592
(100 %)
6 diff
(99.0 %id)
DB156452 thymus .a 67 to 643 2 to 578   capped   577/577
(100 %)
1 diff
(99.9 %id)
BM827438 stomach .a 68 to 595 1 to 529       529/529
(100 %)
4 diff
(99.3 %id)
DA014615 adrenal gland .a 69 to 643 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DA167680 amygdala .a 69 to 627 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
DA270930 caudate nucleus .a 69 to 614 2 to 547   capped   546/546
(100 %)
1 diff
(99.9 %id)
DA311277 hippocampus .a 69 to 627 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
DA510935 brain .a 69 to 651 2 to 584   capped   583/583
(100 %)
0 diff
(100 %id)
DA526531 brain .a 69 to 629 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DA679190   .a 69 to 645 2 to 578   capped   577/577
(100 %)
2 diff
(99.7 %id)
DA849794 placenta .a 69 to 606 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
DA945695 Spleen .a 69 to 619 2 to 552   capped   551/551
(100 %)
1 diff
(99.9 %id)
DA951530 Spleen .a 69 to 640 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DB129034 thymus .a 69 to 618 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
DB264444 uterus .a 69 to 628 2 to 562   capped   561/562
(99 %)
3 diff
(99.5 %id)
DA305671 hippocampus .a 70 to 636 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DA428100 colon .a 70 to 619 2 to 551   capped   550/550
(100 %)
1 diff
(99.9 %id)
BP234591 coronary artery .a 70 to 651 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DA659680   .a 70 to 598 2 to 531   capped   530/530
(100 %)
2 diff
(99.7 %id)
DA684053   .a 70 to 529 2 to 461   capped   460/460
(100 %)
0 diff
(100 %id)
DB258298 uterus .a 70 to 632 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA438573 tongue, tumor tissue .a 71 to 642 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA450238 tongue, tumor tissue .a 71 to 616 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
DA790480 brain .a 71 to 614 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
DB133915 thymus .a 72 to 613 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
DA714616   .a 74 to 610 9 to 545   capped   537/537
(100 %)
0 diff
(100 %id)
DA844983 placenta .a 74 to 619 10 to 555   capped   546/546
(100 %)
0 diff
(100 %id)
DN992105 brain, whole brain .a 74 to 435 1 to 362       362/362
(100 %)
3 diff
(99.2 %id)
AA306750   .a 76 to 456 1 to 380       380/380
(100 %)
1 diff
(99.8 %id)
TI_57199260   .a 76 to 821 60 to 804       745/805
(92 %)
12 diff
(98.6 %id)
CB153138 brain .a 78 to 659 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
DA365843 subthalamic nucleus .a 79 to 654 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
DA814108   .a 79 to 629 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
BE410805 choriocarcinoma, placenta .a 80 to 720 16 to 656       641/656
(97 %)
6 diff
(99.1 %id)
BI821569 pooled brain, lung, testis .a 84 to 821 1 to 737       737/738
(99 %)
6 diff
(99.2 %id)
BE387126 melanotic melanoma, skin .a 98 to 646 100 to 656       557/660
(84 %)
19 diff
(97.2 %id)
BE387066 melanotic melanoma, skin .a 98 to 641 83 to 631       550/927
(59 %)
14 diff
(98.5 %id)
CD359226 testis .a 98 to 951 15 to 879       868/885
(98 %)
27 diff
(97.0 %id)
BM838507 Ascites, stomach .a 98 to 219 1 to 121       121/121
(100 %)
1 diff
(99.2 %id)
DA704904   .a 137 to 608 2 to 473   capped   472/472
(100 %)
0 diff
(100 %id)
AA884887 pooled .a 158 to 467 1 to 310     Submitted on the opposite strand 310/310
(100 %)
6 diff
(98.1 %id)
BP370505 testis .a 166 to 745 1 to 580       580/580
(100 %)
0 diff
(100 %id)
DB022455 testis .a 192 to 755 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
DB057147 testis .a 203 to 735 2 to 534   capped   533/533
(100 %)
0 diff
(100 %id)
DB041961 testis .a 208 to 778 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DB042312 testis .a 220 to 770 2 to 552   capped   551/551
(100 %)
2 diff
(99.7 %id)
DB044554 testis .a 222 to 740 2 to 520   capped   519/519
(100 %)
1 diff
(99.9 %id)
BM468630 leiomyosarcoma, uterus .a 223 to 1204 1 to 992       992/1039
(95 %)
14 diff
(98.7 %id)
DB036714 testis .a 223 to 786 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DB443024 testis .a 238 to 657 1 to 417       417/417
(100 %)
6 diff
(98.6 %id)
DB055578 testis .a 245 to 818 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DB056902 testis .a 245 to 773 2 to 530   capped   529/529
(100 %)
0 diff
(100 %id)
DB462018 testis .a 258 to 739 1 to 482       482/482
(100 %)
0 diff
(100 %id)
DB023849 testis .a 259 to 816 2 to 559   capped   558/558
(100 %)
2 diff
(99.7 %id)
DB024094 testis .a 259 to 816 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DB033368 testis .a 259 to 806 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
DB035545 testis .a 259 to 564 2 to 307   capped   306/306
(100 %)
0 diff
(100 %id)
DB038003 testis .a 259 to 827 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
DB038616 testis .a 259 to 830 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DB041275 testis .a 259 to 815 2 to 558   capped   557/557
(100 %)
1 diff
(99.9 %id)
BG719814 testis .a 270 to 1114 1 to 841       841/841
(100 %)
11 diff
(98.7 %id)
AL136834 testis .a 275 to 2574 1 to 2300 exact available from DKFZ, AAA   2300/2300
(100 %)
0 diff
(100 %id)
CD358312 testis .a 276 to 986 1 to 728       728/964
(75 %)
23 diff
(97.7 %id)
DB032579 testis .a 276 to 826 2 to 552   capped   551/551
(100 %)
0 diff
(100 %id)
DB025060 testis .a 282 to 836 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
CX754720 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 296 to 960 1 to 662       662/874
(75 %)
7 diff
(99.2 %id)
DA882837   .a 322 to 882 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
AA351901   .a 381 to 614 1 to 238       238/238
(100 %)
4 diff
(98.4 %id)
CV026288 mixed .a 381 to 914 1 to 534       534/534
(100 %)
6 diff
(98.9 %id)
AW962244   .a 382 to 921 1 to 546       546/549
(99 %)
18 diff
(96.8 %id)
BQ719260 sympathetic trunk .a 414 to 1174 1 to 768       768/1006
(76 %)
13 diff
(98.8 %id)
DB046245 testis .a 462 to 1025 2 to 567   capped   566/566
(100 %)
3 diff
(99.5 %id)
DA926608 small intestine .a 509 to 1072 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
R19247 whole brain .a 637 to 1085 456 to 1     Submitted on the opposite strand 456/456
(100 %)
10 diff
(97.9 %id)
CD705603 normal nasopharynx .a 641 to 976 24 to 359       336/359
(93 %)
5 diff
(98.7 %id)
T78203 whole brain .a 723 to 1085 362 to 1     Submitted on the opposite strand 362/362
(100 %)
3 diff
(99.2 %id)
AK026303 human small intestine .a 768 to 2574 1 to 1807   available from FLJ, AAA   1807/1807
(100 %)
0 diff
(100 %id)
F11264 brain, total brain .a 824 to 1109 286 to 1       286/286
(100 %)
0 diff
(100 %id)
H24098 whole brain .a 859 to 1108 249 to 1     Submitted on the opposite strand 249/254
(98 %)
3 diff
(98.9 %id)
Z44990 brain, total brain .a 911 to 1109 199 to 1       199/209
(95 %)
0 diff
(100 %id)
R35589 whole brain .a 952 to 1295 1 to 346       346/441
(78 %)
5 diff
(98.9 %id)
BF880015 lung_tumor .a 966 to 1305 341 to 1     Submitted on the opposite strand 341/341
(100 %)
3 diff
(99.2 %id)
DA001347   .a 1192 to 1701 2 to 511   capped   510/511
(99 %)
2 diff
(99.7 %id)
BI828455 brain, medulla .a 1310 to 1966 1 to 657       657/657
(100 %)
0 diff
(100 %id)
CA488095   .a 1311 to 2085 1 to 784       784/979
(80 %)
20 diff
(98.0 %id)
TI_57175060   .a 1314 to 1966 62 to 714       654/714
(91 %)
6 diff
(99.2 %id)
H67831 liver and spleen .a 1366 to 1742 1 to 381       381/489
(77 %)
10 diff
(98.0 %id)
AI697954 carcinoid, lung .a 1576 to 1896 1 to 321     Submitted on the opposite strand 321/321
(100 %)
0 diff
(100 %id)
TI_159715984   .a 1641 to 2574 1024 to 95   AAA   930/1047
(88 %)
13 diff
(98.8 %id)
EC538891 Prostate .a 1666 to 1775 110 to 1       110/110
(100 %)
0 diff
(100 %id)
EC552834 Prostate .a 1669 to 1773 103 to 4       100/104
(96 %)
3 diff
(97.2 %id)
AA005029 liver and spleen .a 1739 to 2179 1 to 444   fully sequenced,   444/444
(100 %)
2 diff
(99.6 %id)
CB852442 Human Lung Epithelial cells, lung .a 1806 to 2574 787 to 19   AAA   769/769
(100 %)
0 diff
(100 %id)
BG217836   .a 1915 to 2534 1 to 622       622/1145
(54 %)
50 diff
(95.7 %id)
BM728139 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 1932 to 2457 1 to 526       526/526
(100 %)
0 diff
(100 %id)
CA426723 cell lines, Chondrosarcoma .a 1935 to 2574 658 to 19   AAA   640/640
(100 %)
0 diff
(100 %id)
AV706447 adrenal gland .a 1962 to 2579 1 to 618       618/656
(94 %)
3 diff
(99.6 %id)
BG253598 adenocarcinoma, cell line, Liver .a 2004 to 2574 1 to 571   AAA   571/571
(100 %)
0 diff
(100 %id)
BU624242 cell lines, Enchondroma .a 2016 to 2574 577 to 19   AAA   559/559
(100 %)
0 diff
(100 %id)
BF742981 breast .a 2037 to 2450 428 to 15     Submitted on the opposite strand 414/428
(96 %)
0 diff
(100 %id)
AI744715 colon .a 2046 to 2576 533 to 3       531/533
(99 %)
0 diff
(100 %id)
AI972973 Prostate .a 2055 to 2574 520 to 1       520/520
(100 %)
0 diff
(100 %id)
AA824364   .a 2070 to 2576 508 to 2       507/508
(99 %)
0 diff
(100 %id)
AA889665   .a 2070 to 2576 511 to 5       507/511
(99 %)
0 diff
(100 %id)
BM069541 Islets of Langerhans, Pancreas .a 2083 to 2578 508 to 13   AAA   496/496
(100 %)
1 diff
(99.8 %id)
DB527442 testis .a 2108 to 2573 1 to 466     Submitted on the opposite strand 466/467
(99 %)
1 diff
(99.8 %id)
DB506839 testis .a 2120 to 2573 1 to 456     Submitted on the opposite strand 456/457
(99 %)
20 diff
(95.7 %id)
AI024417   .a 2126 to 2576 456 to 6       451/456
(98 %)
0 diff
(100 %id)
AA713598 germinal center B cell .a 2134 to 2580 457 to 11   AAA   447/447
(100 %)
2 diff
(99.6 %id)
BE048359 Kidney .a 2135 to 2574 452 to 13   AAA   440/440
(100 %)
3 diff
(99.4 %id)
DB525707 testis .a 2138 to 2574 1 to 437     Submitted on the opposite strand 437/437
(100 %)
0 diff
(100 %id)
AI298362 carcinoid, lung .a 2144 to 2574 443 to 13   AAA   431/431
(100 %)
0 diff
(100 %id)
AI984734 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 2144 to 2576 431 to 1       431/431
(100 %)
4 diff
(99.1 %id)
DB508502 testis .a 2151 to 2573 1 to 423     Submitted on the opposite strand 423/424
(99 %)
1 diff
(99.8 %id)
AI184248 placenta .a 2152 to 2573 422 to 1       422/422
(100 %)
0 diff
(100 %id)
AA005030 liver and spleen .a 2153 to 2574 432 to 1   fully sequenced,   432/432
(100 %)
11 diff
(97.5 %id)
AA405694.
matches multiple genes
  .a 2159 to 2576 420 to 3     also hits gene CDC42BPB 418/420
(99 %)
0 diff
(100 %id)
DB507960 testis .a 2163 to 2573 1 to 413     Submitted on the opposite strand 413/414
(99 %)
17 diff
(95.9 %id)
AI422666 Prostate .a 2164 to 2506 412 to 70       343/412
(83 %)
0 diff
(100 %id)
AI991448 Kidney .a 2166 to 2574 409 to 1       409/413
(99 %)
0 diff
(100 %id)
AI634759 Kidney .a 2171 to 2574 418 to 15   AAA   404/404
(100 %)
1 diff
(99.8 %id)
AI914103 carcinoid, lung .a 2174 to 2576 404 to 2       403/404
(99 %)
0 diff
(100 %id)
AA701557 liver and spleen .a 2182 to 2574 393 to 1       393/393
(100 %)
0 diff
(100 %id)
BE467369 carcinoid, lung .a 2193 to 2576 385 to 2       384/385
(99 %)
0 diff
(100 %id)
BG055366 carcinoid, lung .a 2194 to 2576 388 to 6       383/388
(98 %)
0 diff
(100 %id)
DB530362 hippocampus .a 2197 to 2577 1 to 381     Submitted on the opposite strand 381/381
(100 %)
7 diff
(98.2 %id)
AW136684   .a 2214 to 2574 378 to 18   AAA   361/380
(95 %)
0 diff
(100 %id)
BX103963 uterus .a 2219 to 2574 1 to 356   AAA   356/356
(100 %)
0 diff
(100 %id)
AA040838 uterus .a 2219 to 2569 1 to 351   fully sequenced,   351/351
(100 %)
4 diff
(98.9 %id)
BG149897 carcinoid, lung .a 2230 to 2576 350 to 4       347/350
(99 %)
0 diff
(100 %id)
AA704497 liver and spleen .a 2254 to 2574 321 to 1       321/321
(100 %)
1 diff
(99.7 %id)
H68102 liver and spleen .a 2265 to 2576 322 to 1       322/322
(100 %)
14 diff
(95.7 %id)
AW028520 Kidney .a 2281 to 2578 314 to 17       298/314
(94 %)
0 diff
(100 %id)
BE646257 Prostate .a 2293 to 2581 290 to 2       289/290
(99 %)
0 diff
(100 %id)
AI309257 2 pooled tumors (clear cell type), Kidney .a 2324 to 2576 255 to 3       253/255
(99 %)
0 diff
(100 %id)
AI001743   .a 2337 to 2576 242 to 3       240/242
(99 %)
0 diff
(100 %id)
AA040173 uterus .a 2350 to 2574 233 to 1   fully sequenced,   233/233
(100 %)
4 diff
(98.3 %id)
AW090628 brain, tumor, 5 pooled (see description) .a 2367 to 2576 211 to 2       210/211
(99 %)
0 diff
(100 %id)
AA748689 germinal center B cell .a 2376 to 2581 211 to 6       206/211
(97 %)
0 diff
(100 %id)
AA846075 Spleen .a 2456 to 2576 121 to 1       121/121
(100 %)
0 diff
(100 %id)
AI632241 pooled germ cell tumors .a 2458 to 2574 145 to 29   AAA   117/117
(100 %)
2 diff
(98.3 %id)
NM_022173.2   .b 1 to 4653 1 to 4653 exact RefSeq,   4653/4653
(100 %)
0 diff
(100 %id)
BM801053 embryonal carcinoma, cell line, testis .b 29 to 894 1 to 872   tiling clone,   872/1086
(80 %)
14 diff
(98.8 %id)
BQ879464 dorsal root ganglia .b 44 to 893 1 to 857       857/908
(94 %)
15 diff
(98.4 %id)
CN396945 embryonic stem cells, DMSO-treated H9 cellline .b 47 to 863 1 to 817       817/817
(100 %)
1 diff
(99.9 %id)
DR156476 human embryonic stem cells differentiated toan early endodermal cell type .b 48 to 869 1 to 822       822/822
(100 %)
0 diff
(100 %id)
BX353068 Neuroblastoma Cot 10-normalized .b 90 to 947 1 to 857     Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 857/857
(100 %)
6 diff
(99.3 %id)
CN396947 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 94 to 868 10 to 783       774/783
(98 %)
2 diff
(99.8 %id)
TI_154154939   .b 307 to 862 89 to 646       558/655
(85 %)
16 diff
(97.6 %id)
CN396949 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 337 to 1053 1 to 717       717/717
(100 %)
0 diff
(100 %id)
CR597363 Neuroblastoma Cot 10-normalized .b 527 to 2162 1 to 1636   tiling clone,   1636/1636
(100 %)
0 diff
(100 %id)
AL520242 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .b 528 to 1427 1 to 901   fully sequenced,   901/901
(100 %)
6 diff
(99.4 %id)
BE815135 breast_normal .b 569 to 1013 22 to 466       445/466
(95 %)
13 diff
(97.3 %id)
BE815137 breast_normal .b 569 to 1013 12 to 455       444/455
(97 %)
14 diff
(97.0 %id)
BE815147 breast_normal .b 569 to 1013 12 to 456       445/462
(96 %)
14 diff
(97.0 %id)
DR157578 human embryonic stem cells differentiated toan early endodermal cell type .b 661 to 1421 1 to 760       760/760
(100 %)
1 diff
(99.9 %id)
AA189171   .b 690 to 1276 1 to 584     Submitted on the opposite strand 587/585
(100 %)
15 diff
(97.5 %id)
AA373560 lung .b 691 to 1021 1 to 328       328/328
(100 %)
8 diff
(97.6 %id)
BF747021 breast .b 715 to 853 142 to 1     Submitted on the opposite strand 142/142
(100 %)
13 diff
(90.9 %id)
TI_57244577   .b 741 to 1553 36 to 851       816/851
(95 %)
13 diff
(98.5 %id)
BI915228 brain .b 744 to 1553 1 to 813       813/813
(100 %)
7 diff
(99.2 %id)
T83984 liver and spleen .b 755 to 983 1 to 232       232/437
(53 %)
5 diff
(98.9 %id)
AA334724   .b 766 to 1111 1 to 350       350/350
(100 %)
7 diff
(98.0 %id)
N39777.
matches multiple genes
placenta .b 833 to 1231 1 to 402     also hits gene CHRDL1 402/402
(100 %)
5 diff
(98.8 %id)
CU450428 epidermis .b 863 to 1442 594 to 14     Submitted on the opposite strand 581/595
(97 %)
3 diff
(99.5 %id)
CU455562 epidermis .b 863 to 1442 592 to 12     Submitted on the opposite strand 581/593
(97 %)
3 diff
(99.5 %id)
CN295702 embryonic stem cells, cell lines H1, H7, andH9 .b 878 to 1582 12 to 716       705/716
(98 %)
0 diff
(100 %id)
CN295697 embryonic stem cells, DMSO-treated H9 cellline .b 902 to 1664 1 to 763       763/763
(100 %)
0 diff
(100 %id)
AW382636 head_neck .b 981 to 1227 250 to 1       250/252
(99 %)
12 diff
(95.3 %id)
BE153178 head_neck .b 981 to 1244 274 to 11     Submitted on the opposite strand 264/284
(92 %)
0 diff
(100 %id)
BE706543 head_neck .b 981 to 1244 12 to 276       266/280
(95 %)
16 diff
(94.3 %id)
BE706555 head_neck .b 981 to 1244 13 to 276       265/280
(94 %)
11 diff
(96.1 %id)
BE706674 head_neck .b 981 to 1184 14 to 217       205/217
(94 %)
6 diff
(97.3 %id)
BQ349805 head_neck .b 981 to 1226 255 to 8       248/265
(93 %)
2 diff
(99.3 %id)
BQ350434 head_neck .b 981 to 1244 277 to 14       264/287
(91 %)
0 diff
(100 %id)
AA215769 germinal center B cell .b 986 to 1333 1 to 350       350/355
(98 %)
7 diff
(98.1 %id)
AW382642 head_neck .b 989 to 1216 229 to 2       228/229
(99 %)
1 diff
(99.6 %id)
AA427663 ovarian tumor, ovary .b 1003 to 1477 1 to 476       476/633
(75 %)
9 diff
(98.6 %id)
AW382645 head_neck .b 1020 to 1232 216 to 5       212/216
(98 %)
0 diff
(100 %id)
N47765 multiple sclerosis lesions .b 1024 to 1431 1 to 413   fully sequenced,   413/413
(100 %)
8 diff
(98.1 %id)
TI_57163087   .b 1037 to 1766 31 to 758       728/759
(95 %)
8 diff
(99.0 %id)
BI838504 pooled pancreas and spleen .b 1038 to 1832 1 to 794       794/794
(100 %)
2 diff
(99.8 %id)
TI_57163143   .b 1038 to 1832 77 to 870       794/870
(91 %)
9 diff
(99.0 %id)
BI838448 pooled pancreas and spleen .b 1039 to 1766 1 to 726       726/727
(99 %)
3 diff
(99.6 %id)
AA490391 germinal center B cell .b 1045 to 1443 1 to 399       399/399
(100 %)
0 diff
(100 %id)
AW390489 stomach .b 1052 to 1297 1 to 248       248/248
(100 %)
23 diff
(90.8 %id)
BE153046 head_neck .b 1053 to 1244 222 to 21     Submitted on the opposite strand 200/222
(90 %)
6 diff
(97.3 %id)
AW582011 stomach .b 1066 to 1636 569 to 1       569/569
(100 %)
5 diff
(99.2 %id)
BU429019 lymph .b 1211 to 1675 1 to 465       465/465
(100 %)
5 diff
(99.0 %id)
AL520241 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .b 1397 to 2162 763 to 1   fully sequenced,   763/763
(100 %)
10 diff
(98.7 %id)
T83985 liver and spleen .b 1397 to 1769 375 to 1       375/427
(87 %)
5 diff
(98.9 %id)
N34504 multiple sclerosis lesions .b 1401 to 1643 246 to 1   fully sequenced,   246/246
(100 %)
3 diff
(98.8 %id)
DA931153 Spleen .b 1768 to 2488 2 to 723   capped   722/732
(98 %)
4 diff
(99.5 %id)
AU132464   .b 1770 to 2472 2 to 703   capped   702/702
(100 %)
3 diff
(99.6 %id)
AU136831 placenta .b 1934 to 2667 2 to 742   tiling clone, capped   741/741
(100 %)
12 diff
(98.4 %id)
BX331618 Neuroblastoma Cot 10-normalized .b 2042 to 2159 130 to 13   AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 604/872
(69 %)
74 diff
(91.6 %id)
AA427664 ovarian tumor, ovary .b 2075 to 2655 574 to 1       574/577
(99 %)
28 diff
(95.2 %id)
DA568641 whole embryo, mainly head .b 2398 to 3214 2 to 818   tiling clone, capped   817/817
(100 %)
8 diff
(99.1 %id)
BE536563 cervix .b 2820 to 3569 1 to 752       752/863
(87 %)
27 diff
(96.9 %id)
DA731437   .b 2851 to 3833 2 to 990   capped   989/994
(99 %)
28 diff
(97.2 %id)
BM821054 stomach .b 2882 to 3452 1 to 570       570/570
(100 %)
3 diff
(99.5 %id)
AA213522 germinal center B cell .b 2889 to 3229 1 to 345       345/345
(100 %)
4 diff
(98.9 %id)
BG111685 Bone, osteosarcoma, cell line .b 2914 to 3647 1 to 729       729/943
(77 %)
12 diff
(98.8 %id)
DN917109   .b 2930 to 3518 638 to 50       589/638
(92 %)
0 diff
(100 %id)
CR737355 melanocyte .b 2938 to 3581 1 to 644       644/644
(100 %)
0 diff
(100 %id)
FN156609 breast carcinoma .b 2938 to 3057 123 to 1     Submitted on the opposite strand 123/123
(100 %)
3 diff
(97.6 %id)
AA570278 colon, colon tumor RER+ .b 2944 to 3362 423 to 5       419/423
(99 %)
0 diff
(100 %id)
BG261342 bladder, transitional cell papilloma, cell line .b 2949 to 3730 1 to 786       786/910
(86 %)
16 diff
(98.3 %id)
AA738021 pooled germ cell tumors .b 2950 to 3440 491 to 1       491/491
(100 %)
0 diff
(100 %id)
FN054118 breast carcinoma .b 2962 to 3080 119 to 1     Submitted on the opposite strand 119/119
(100 %)
0 diff
(100 %id)
CN404343 embryonic stem cells, DMSO-treated H9 cellline .b 2973 to 3536 1 to 564       564/564
(100 %)
3 diff
(99.5 %id)
TI_149288357   .b 2978 to 3893 1015 to 108       908/1125
(80 %)
0 diff
(100 %id)
AA865559 pooled germ cell tumors .b 2986 to 3241 256 to 1       256/256
(100 %)
0 diff
(100 %id)
AJ711563 heart .b 3006 to 3539 1 to 534       534/534
(100 %)
3 diff
(99.5 %id)
CK003373 brain/CNS, Human Brain - Cerebellar Cortex .b 3006 to 3666 1 to 659       659/659
(100 %)
3 diff
(99.6 %id)
F08710 brain, total brain .b 3023 to 3241 1 to 219       219/219
(100 %)
0 diff
(100 %id)
AI565461 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 3038 to 3441 405 to 3       403/405
(99 %)
0 diff
(100 %id)
AV725151 hypothalamus .b 3067 to 3805 1 to 743       743/841
(88 %)
6 diff
(99.3 %id)
AI524454 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 3092 to 3440 350 to 1       350/350
(100 %)
1 diff
(99.8 %id)
AW591787 lymph node, lymphoma, follicular mixed small and largecell .b 3099 to 3370 272 to 1       272/272
(100 %)
0 diff
(100 %id)
FN098115 breast carcinoma .b 3121 to 3213 93 to 1     Submitted on the opposite strand 93/93
(100 %)
0 diff
(100 %id)
CR607569 fetal brain .b 3138 to 4629 1 to 1492   tiling clone,   1492/1492
(100 %)
0 diff
(100 %id)
BI439053 Pancreas, Purified pancreatic islet .b 3145 to 3760 6 to 621       616/621
(99 %)
6 diff
(99.1 %id)
AW967722   .b 3191 to 3890 702 to 1     Submitted on the opposite strand 702/705
(99 %)
11 diff
(98.5 %id)
AF090093 cochlea .b 3199 to 3892 702 to 1     Submitted on the opposite strand 702/712
(98 %)
11 diff
(98.5 %id)
D60881   .b 3204 to 3667 1 to 463       463/464
(99 %)
2 diff
(99.6 %id)
D52979   .b 3205 to 3610 1 to 406   fully sequenced,   406/406
(100 %)
2 diff
(99.6 %id)
AW994472 breast_normal .b 3207 to 3444 240 to 5     Submitted on the opposite strand 236/240
(98 %)
0 diff
(100 %id)
BM839067 stomach .b 3235 to 3767 1 to 534       534/534
(100 %)
3 diff
(99.5 %id)
T31499 colon, embryo .b 3252 to 3479 1 to 228       228/228
(100 %)
0 diff
(100 %id)
BM711447 eye, fetal eyes .b 3258 to 3743 1 to 486       486/486
(100 %)
0 diff
(100 %id)
CK429602 eye, lacrimal gland .b 3286 to 3929 1 to 644       644/644
(100 %)
0 diff
(100 %id)
BF978492 melanotic melanoma, high MDR, skin .b 3295 to 3803 1 to 510       510/510
(100 %)
1 diff
(99.9 %id)
AW051358 pooled .b 3318 to 3890 572 to 1       572/572
(100 %)
3 diff
(99.5 %id)
AA779686   .b 3357 to 3893 544 to 8       537/544
(98 %)
0 diff
(100 %id)
AI985681 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 3375 to 3892 519 to 1       519/519
(100 %)
2 diff
(99.7 %id)
AI923856 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 3377 to 3892 516 to 1       516/516
(100 %)
0 diff
(100 %id)
AW473431 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .b 3393 to 3892 500 to 1       500/500
(100 %)
3 diff
(99.4 %id)
AA425529   .b 3399 to 3892 494 to 1     Submitted on the opposite strand 494/494
(100 %)
0 diff
(100 %id)
AI565068 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 3399 to 3891 492 to 1       492/492
(100 %)
1 diff
(99.8 %id)
AI922566 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 3401 to 3893 497 to 5       493/497
(99 %)
0 diff
(100 %id)
AA599589   .b 3403 to 3892 490 to 1       490/490
(100 %)
0 diff
(100 %id)
DB577556 hypothalamus .b 3412 to 3891 1 to 480     Submitted on the opposite strand 480/480
(100 %)
2 diff
(99.6 %id)
AI911598 colon .b 3424 to 3891 468 to 1       468/468
(100 %)
2 diff
(99.6 %id)
AI144500 heart .b 3434 to 3888 457 to 3       455/457
(99 %)
0 diff
(100 %id)
AI218206 pooled .b 3435 to 3892 458 to 1       458/458
(100 %)
0 diff
(100 %id)
AA937859 metastatic prostate bone lesion .b 3459 to 3893 439 to 4       436/439
(99 %)
0 diff
(100 %id)
AI619711 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 3461 to 3891 431 to 1       431/431
(100 %)
0 diff
(100 %id)
BE351014 malignant melanoma, metastatic to lymphnode, skin .b 3463 to 3891 429 to 1       429/429
(100 %)
0 diff
(100 %id)
BF940696 fibrotheoma, ovary .b 3464 to 3891 428 to 1       428/428
(100 %)
1 diff
(99.8 %id)
AI923491 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 3465 to 3893 431 to 3       429/431
(99 %)
0 diff
(100 %id)
AI469493 colon, moderately-differentiated adenocarcinoma .b 3477 to 3891 415 to 1       415/415
(100 %)
0 diff
(100 %id)
BE245111 leukopheresis .b 3505 to 3889 385 to 1       385/385
(100 %)
2 diff
(99.5 %id)
BM311236 Pancreas, Purified pancreatic islet .b 3526 to 4008 1 to 482       482/482
(100 %)
1 diff
(99.8 %id)
FN065443 breast carcinoma .b 3530 to 3627 99 to 1     Submitted on the opposite strand 99/100
(99 %)
1 diff
(99.0 %id)
AA600357   .b 3537 to 3889 397 to 45   AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 353/353
(100 %)
0 diff
(100 %id)
AA962013 Kidney, kidney tumor .b 3540 to 3891 380 to 29   AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 352/352
(100 %)
0 diff
(100 %id)
AI633087 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 3575 to 3891 335 to 21   AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 315/315
(100 %)
3 diff
(99.1 %id)
D60230   .b 3580 to 3891 312 to 1   fully sequenced,   312/312
(100 %)
0 diff
(100 %id)
FN105254 breast carcinoma .b 3770 to 3892 125 to 1     Submitted on the opposite strand 125/128
(97 %)
3 diff
(97.7 %id)
BU675943 lung, Primary Lung Epithelial Cells .b 3831 to 4337 525 to 19   AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 507/511
(99 %)
2 diff
(99.7 %id)
AA328984   .b 3883 to 4187 1 to 305       305/305
(100 %)
0 diff
(100 %id)
AA479542 ovarian tumor, ovary .b 3948 to 4360 1 to 413   fully sequenced,   413/413
(100 %)
0 diff
(100 %id)
AI694665 carcinoid, lung .b 3997 to 4527 1 to 531     Submitted on the opposite strand 531/531
(100 %)
4 diff
(99.3 %id)
CA413507 Chondrosarcoma Grade II, Left Pelvis .b 3999 to 4652 672 to 19   AAA   654/654
(100 %)
2 diff
(99.7 %id)
BI438724 Pancreas, Purified pancreatic islet .b 4058 to 4646 589 to 1       589/589
(100 %)
0 diff
(100 %id)
AI859593 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b 4082 to 4647 566 to 1       566/566
(100 %)
0 diff
(100 %id)
AI859598 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b 4082 to 4647 566 to 1       566/566
(100 %)
0 diff
(100 %id)
DB369459   .b 4133 to 4651 521 to 1       521/525
(99 %)
10 diff
(98.1 %id)
DB332361 Spleen .b 4139 to 4651 514 to 1       514/514
(100 %)
3 diff
(99.5 %id)
BM311825 Pancreas, Purified pancreatic islet .b 4146 to 4653 508 to 1       508/508
(100 %)
1 diff
(99.9 %id)
AA744247 germinal center B cell .b 4152 to 4651 515 to 16   AAA   500/500
(100 %)
0 diff
(100 %id)
AI860638 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 4153 to 4648 495 to 1       495/495
(100 %)
1 diff
(99.8 %id)
DB375668 placenta .b 4153 to 4651 498 to 1       498/500
(99 %)
17 diff
(96.6 %id)
DB572403 hypothalamus .b 4171 to 4651 1 to 481     Submitted on the opposite strand 481/481
(100 %)
0 diff
(100 %id)
AI274817 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .b 4172 to 4651 494 to 15   AAA   480/480
(100 %)
2 diff
(99.6 %id)
AW273292 serous papillary carcinoma, high grade, 2pooled tumors, uterus .b 4172 to 4651 480 to 1       480/480
(100 %)
2 diff
(99.6 %id)
AA214539 germinal center B cell .b 4189 to 4628 444 to 1       444/444
(100 %)
4 diff
(99.1 %id)
DB355175 whole embryo, mainly head .b 4193 to 4651 462 to 1       462/512
(90 %)
12 diff
(97.7 %id)
AA775259 whole brain .b 4213 to 4652 440 to 1       440/440
(100 %)
0 diff
(100 %id)
AI186061 lung .b 4215 to 4651 447 to 11   AAA   437/437
(100 %)
1 diff
(99.8 %id)
BU754310 placenta .b 4233 to 4651 437 to 19   AAA   419/419
(100 %)
1 diff
(99.8 %id)
AA649204 germinal center B cell .b 4271 to 4521 251 to 1       251/251
(100 %)
0 diff
(100 %id)
AI619856 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .b 4292 to 4652 361 to 1       361/361
(100 %)
2 diff
(99.5 %id)
BE328527 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .b 4299 to 4653 355 to 1   tiling clone,   355/355
(100 %)
1 diff
(99.8 %id)
AA302626 adipose tissue, white .b 4309 to 4651 344 to 1       344/344
(100 %)
1 diff
(99.8 %id)
BF198030 skin, normal, 4 pooled samples .b 4313 to 4651 339 to 1       339/339
(100 %)
1 diff
(99.8 %id)
AA477643 ovarian tumor, ovary .b 4330 to 4652 324 to 1   fully sequenced,   324/324
(100 %)
1 diff
(99.7 %id)
EC529190 Prostate .b 4402 to 4506 1 to 105       105/105
(100 %)
0 diff
(100 %id)
AW576136 lymph .b 4429 to 4649 238 to 18   AAA   221/221
(100 %)
3 diff
(98.7 %id)
F04979 brain, total brain .b 4478 to 4651 174 to 1       174/174
(100 %)
0 diff
(100 %id)
NM_022037.2   .c 1 to 4620 1 to 4620 exact RefSeq,   4620/4620
(100 %)
0 diff
(100 %id)
CN295705 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .c 14 to 707 1 to 692   tiling clone,   692/692
(100 %)
2 diff
(99.8 %id)
BQ937619 leiomyosarcoma, uterus .c 25 to 923 1 to 897   tiling clone,   897/897
(100 %)
9 diff
(99.0 %id)
CX759851 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .c 49 to 659 1 to 609     Submitted on the opposite strand 609/799
(76 %)
16 diff
(98.0 %id)
BQ423873 eye, retinoblastoma .c 63 to 860 1 to 803       803/863
(93 %)
9 diff
(99.0 %id)
CN295707 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 85 to 837 1 to 753       753/753
(100 %)
6 diff
(99.3 %id)
M77142   .c 162 to 2380 1 to 2218 E105Q tiling clone, AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 2218/2218
(100 %)
3 diff
(99.9 %id)
AA973786 pooled germ cell tumors .c 344 to 657 313 to 1       313/325
(96 %)
5 diff
(98.5 %id)
BQ072754 leukocyte .d 1 to 819 1 to 825   tiling clone,   825/1101
(74 %)
10 diff
(99.1 %id)
CN295703 embryonic stem cells, cell lines H1, H7, andH9 .d 464 to 1061 1 to 600   tiling clone,   600/601
(99 %)
5 diff
(99.2 %id)
CB151216 cervix, Uterine .e-u 1 to 551 1 to 547   tiling clone,   547/547
(100 %)
5 diff
(99.1 %id)
CN291485 embryonic stem cells, DMSO-treated H9 cellline .e-u 80 to 398 1 to 319       319/319
(100 %)
1 diff
(99.7 %id)
DA856519 placenta .e-u 360 to 920 2 to 566   tiling clone, to resequence, capped   565/565
(100 %)
8 diff
(98.6 %id)
AK024108 whole embryo, mainly head .e-u 1015 to 2825 1 to 1810   tiling clone, available from FLJ,   1810/1810
(100 %)
8 diff
(99.6 %id)
AU119713 whole embryo, mainly head .e-u 1016 to 1488 2 to 475   capped   474/474
(100 %)
8 diff
(98.4 %id)
AU121907 mammary gland .e-u 1039 to 1603 2 to 566   tiling clone, capped   565/565
(100 %)
8 diff
(98.6 %id)
T96010 liver and spleen .e-u 2000 to 2388 1 to 396       396/396
(100 %)
10 diff
(97.5 %id)
AW963288   .e-u 2249 to 2824 571 to 1   tiling clone, Submitted on the opposite strand 571/635
(89 %)
7 diff
(98.9 %id)
DB361152 mammary gland .e-u 2257 to 2825 568 to 1       568/571
(99 %)
12 diff
(97.9 %id)
AU145983 whole embryo, mainly head .e-u 2265 to 2825 559 to 1       559/572
(97 %)
6 diff
(99.0 %id)
AI207008 pooled germ cell tumors .e-u 2340 to 2659 1 to 320     Submitted on the opposite strand 320/320
(100 %)
1 diff
(99.7 %id)
AI918689 pooled germ cell tumors .e-u 2340 to 2628 1 to 289     Submitted on the opposite strand 289/289
(100 %)
1 diff
(99.7 %id)
F32794 pectoral muscle (after mastectomy) .e-u 2381 to 2833 1 to 453       453/453
(100 %)
0 diff
(100 %id)
R95895 liver and spleen .e-u 2432 to 2830 411 to 3       409/423
(96 %)
0 diff
(100 %id)
DA176865 amygdala .e-u 2472 to 2999 2 to 529   tiling clone, capped   528/528
(100 %)
0 diff
(100 %id)
T95905 liver and spleen .e-u 2503 to 2816 314 to 1       314/316
(99 %)
5 diff
(98.5 %id)
AA312888   .e-u 2510 to 2835 331 to 2       330/331
(99 %)
0 diff
(100 %id)
AA565812 colon, tumor .e-u 2556 to 2828 273 to 1       273/273
(100 %)
3 diff
(99.0 %id)
CB218538 mandible, pooled .e-u 2712 to 3068 236 to 595   tiling clone, Submitted on the opposite strand 360/595
(60 %)
6 diff
(99.0 %id)
BF823738 kidney_tumor .e-u 3019 to 3275 1 to 257   tiling clone,   257/269
(95 %)
2 diff
(99.3 %id)
BX487430   .e-u 3072 to 3429 1 to 359       359/359
(100 %)
1 diff
(99.8 %id)
DB104589 thymus .e-u 3090 to 3635 2 to 548   tiling clone, capped   547/547
(100 %)
1 diff
(99.9 %id)
DB328909 placenta .e-u 3438 to 3992 555 to 1   to resequence,   555/556
(99 %)
0 diff
(100 %id)
CX761232 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .e-u 3487 to 4192 1 to 704   tiling clone, Submitted on the opposite strand 704/708
(99 %)
5 diff
(99.3 %id)
W88862 liver and spleen .e-u 3546 to 3990 446 to 1     Submitted on the opposite strand 446/449
(99 %)
7 diff
(98.5 %id)
W88757 liver and spleen .e-u 3553 to 3974 1 to 432     Submitted on the opposite strand 432/432
(100 %)
13 diff
(97.0 %id)
BU146600 Spleen .e-u 3638 to 4416 1 to 790   tiling clone,   790/905
(87 %)
19 diff
(98.0 %id)
AV684808 hepatocellular carcinoma .e-u 4173 to 4770 20 to 613   tiling clone,   594/613
(96 %)
6 diff
(99.1 %id)
AV690400 hepatocellular carcinoma .e-u 4173 to 4770 22 to 612   tiling clone,   591/615
(96 %)
13 diff
(97.9 %id)
CV807130 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .e-u 4370 to 5168 808 to 7   tiling clone, Submitted on the opposite strand 802/889
(90 %)
0 diff
(100 %id)
AF085822   .e-u 4563 to 5019 1 to 456       456/460
(99 %)
3 diff
(99.4 %id)
R16576 liver and spleen .e-u 4665 to 4999 335 to 1       335/335
(100 %)
5 diff
(98.6 %id)
CA778116 Pancreas, Purified pancreatic islet .e-u 4726 to 5188 1 to 463       463/463
(100 %)
3 diff
(99.4 %id)
CA776197 Pancreas, Purified pancreatic islet .e-u 4924 to 5393 470 to 1   tiling clone,   470/470
(100 %)
2 diff
(99.6 %id)
AA149319 colon, tumor .e-u 5180 to 5498 1 to 324   tiling clone,   324/331
(97 %)
11 diff
(96.7 %id)
AW390084 stomach .e-u 5315 to 5809 497 to 3   tiling clone,   495/497
(99 %)
0 diff
(100 %id)
BX414698 thymus .e-u 5477 to 6458 1 to 979   tiling clone,   979/1004
(97 %)
7 diff
(99.4 %id)
AL539789 brain, fetal brain .e-u 5478 to 6502 1 to 1011   tiling clone,   1011/1073
(94 %)
21 diff
(98.1 %id)
BM799328 Ascites, stomach .e-u 5512 to 6153 1 to 642   tiling clone,   642/642
(100 %)
0 diff
(100 %id)
AW361024 colon .e-u 6167 to 6350 9 to 187       179/187
(95 %)
6 diff
(96.8 %id)
BC015944 Uterus, leiomyosarcoma .f 1 to 819 1 to 819 exact tiling clone, available from MGC, AAA   819/819
(100 %)
0 diff
(100 %id)
BE885448 leiomyosarcoma, uterus .f 21 to 817 1 to 786       786/812
(96 %)
24 diff
(97.1 %id)
AB209211 brain .g 1 to 4786 2 to 4788 exact tiling clone,   4788/4788
(100 %)
4 diff
(100.0 %id)
DB136383 thymus .g 1 to 480 2 to 482   capped   481/481
(100 %)
2 diff
(99.6 %id)
DB506251 hypothalamus .g 17 to 490 1 to 474       474/475
(99 %)
2 diff
(99.6 %id)
CX867570 embryonic stem .g 38 to 754 1 to 717     Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 717/717
(100 %)
0 diff
(100 %id)
AL040667 testis .g 46 to 476 1 to 431       431/432
(99 %)
1 diff
(99.8 %id)
BQ226310 melanotic melanoma, skin .g 48 to 807 1 to 762       762/904
(84 %)
10 diff
(98.9 %id)
BX353700 Neuroblastoma Cot 25-normalized .g 62 to 813 1 to 751   tiling clone,   751/930
(80 %)
8 diff
(99.2 %id)
BE246597 leukopheresis .g 79 to 507 1 to 429       429/429
(100 %)
3 diff
(99.4 %id)
CA391318 eye, RPE/choroid .g 114 to 416 1 to 303       303/303
(100 %)
0 diff
(100 %id)
CN295695 embryonic stem cells, DMSO-treated H9 cellline .g 190 to 442 1 to 253       253/253
(100 %)
0 diff
(100 %id)
CV023306 mixed .g 228 to 869 1 to 639       639/649
(98 %)
5 diff
(99.3 %id)
AW500680 lymph .g 317 to 739 8 to 431       424/431
(98 %)
2 diff
(99.6 %id)
CN295706 embryonic stem cells, DMSO-treated H9 cellline .g 852 to 1376 1 to 525       525/525
(100 %)
0 diff
(100 %id)
BI087000 cervix .g 1111 to 1898 1 to 797       797/805
(99 %)
21 diff
(97.4 %id)
BQ214555 melanotic melanoma, skin .g 1161 to 2049 1 to 896       896/896
(100 %)
8 diff
(99.2 %id)
CN295698 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .g 1251 to 1859 1 to 610       610/610
(100 %)
1 diff
(99.9 %id)
CN295699 embryonic stem cells, cell lines H1, H7, andH9 .g 1283 to 1687 1 to 405       405/405
(100 %)
0 diff
(100 %id)
CB044435 colon, juvenile granulosa tumor .g 1290 to 1900 7 to 617     Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 611/617
(99 %)
6 diff
(99.1 %id)
AW363910 colon .g 1328 to 1859 1 to 532       532/532
(100 %)
3 diff
(99.5 %id)
AW271486 Kidney .g 1332 to 1909 577 to 1       577/577
(100 %)
1 diff
(99.9 %id)
AI245214 Kidney .g 1336 to 1909 570 to 1       570/570
(100 %)
5 diff
(99.2 %id)
BQ924447 sciatic nerve .g 1339 to 2171 1 to 838       838/920
(91 %)
8 diff
(99.2 %id)
AI127600 uterus .g 1350 to 1916 565 to 1       565/565
(100 %)
4 diff
(99.3 %id)
AW578587 colon .g 1351 to 1982 1 to 632       632/632
(100 %)
5 diff
(99.3 %id)
AW859765 colon .g 1353 to 1867 1 to 515       515/515
(100 %)
0 diff
(100 %id)
BE549805 carcinoid, lung .g 1368 to 1908 541 to 1       541/541
(100 %)
0 diff
(100 %id)
AA463804   .g 1370 to 1841 1 to 471       471/471
(100 %)
1 diff
(99.8 %id)
CB956546 Pooled-Glandular .g 1371 to 2047 1 to 684       684/751
(91 %)
19 diff
(97.5 %id)
BG681884 skin, squamous cell carcinoma .g 1374 to 2162 1 to 796       796/799
(99 %)
18 diff
(97.8 %id)
BG057853 blood, lymphocyte .g 1375 to 1919 545 to 1       545/545
(100 %)
0 diff
(100 %id)
AW614841 Kidney .g 1390 to 1909 520 to 1       520/520
(100 %)
0 diff
(100 %id)
BG168926 hypernephroma, cell line, Kidney .g 1401 to 2133 1 to 726       726/934
(77 %)
26 diff
(97.3 %id)
AI800591 pooled .g 1411 to 2132 735 to 16   AAA   720/723
(99 %)
16 diff
(97.8 %id)
AU131017   .g 1411 to 2297 2 to 886   capped   885/886
(99 %)
16 diff
(98.2 %id)
DA408496 thalamus .g 1414 to 1971 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
AW578584 colon .g 1420 to 2062 651 to 10       642/653
(98 %)
0 diff
(100 %id)
CX784508 human embryonic stem cells .g 1422 to 2222 1 to 801       801/801
(100 %)
1 diff
(99.9 %id)
BM995623 Chondrosarcoma, Left Pubic Bone .g 1424 to 2066 661 to 19   AAA   643/643
(100 %)
1 diff
(99.9 %id)
TI_154111683   .g 1433 to 2323 981 to 98   AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 884/968
(91 %)
15 diff
(98.5 %id)
DB501214 hypothalamus .g 1434 to 1913 1 to 480       480/480
(100 %)
0 diff
(100 %id)
N42546 melanocyte .g 1453 to 1822 1 to 369       369/369
(100 %)
3 diff
(99.2 %id)
AW578575 colon .g 1464 to 2047 611 to 26       586/617
(94 %)
0 diff
(100 %id)
AW578589 colon .g 1480 to 2102 626 to 5       622/627
(99 %)
0 diff
(100 %id)
AW379256 head_neck .g 1489 to 2017 538 to 5       534/538
(99 %)
0 diff
(100 %id)
AW578574 colon .g 1501 to 2097 599 to 4       596/599
(99 %)
0 diff
(100 %id)
AW578585 colon .g 1513 to 2102 606 to 19       588/606
(97 %)
0 diff
(100 %id)
AW440090 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .g 1530 to 1910 383 to 1       383/383
(100 %)
1 diff
(99.8 %id)
CN295701 embryonic stem cells, cell lines H1, H7, andH9 .g 1572 to 1807 1 to 236       236/236
(100 %)
0 diff
(100 %id)
BM930658 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .g 1632 to 2052 1 to 421   fully sequenced, Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 421/421
(100 %)
0 diff
(100 %id)
DA514847 brain .g 1637 to 2181 2 to 547   capped   546/546
(100 %)
1 diff
(99.9 %id)
CA448502 Chondrosarcoma, Left Pelvis .g 1654 to 2323 684 to 15   AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 670/670
(100 %)
1 diff
(99.9 %id)
AW859784 colon .g 1699 to 2089 388 to 1       388/388
(100 %)
11 diff
(97.2 %id)
AI130921 heart .g 1699 to 2128 468 to 39   AAA   430/430
(100 %)
3 diff
(99.4 %id)
BM153582 leukopheresis .g 1719 to 2319 617 to 17   AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 601/606
(99 %)
0 diff
(100 %id)
BF743305 breast .g 1724 to 1885 163 to 1     Submitted on the opposite strand 163/163
(100 %)
4 diff
(97.6 %id)
DA496893 brain .g 1736 to 2300 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
AI926963 normal prostate, Prostate .g 1816 to 2555 742 to 5       738/746
(98 %)
0 diff
(100 %id)
TI_154126100   .g 1816 to 2553 817 to 80   tiling clone, AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 738/941
(78 %)
4 diff
(99.6 %id)
DB150629 thymus .g 1836 to 2398 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
BM756513 Ascites, stomach .g 1838 to 2283 1 to 447       447/447
(100 %)
1 diff
(99.8 %id)
BE246558 leukopheresis .g 1842 to 2319 479 to 2       478/479
(99 %)
0 diff
(100 %id)
DB509301 testis .g 1885 to 2318 1 to 434     Submitted on the opposite strand 434/435
(99 %)
1 diff
(99.8 %id)
DA917337 small intestine .g 1905 to 2478 2 to 576   capped   575/575
(100 %)
1 diff
(99.9 %id)
CA416340 Chondrosarcoma Cell line .g 1927 to 2553 645 to 19   AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 627/627
(100 %)
0 diff
(100 %id)
DA355924 subthalamic nucleus .g 1950 to 2513 2 to 565   capped   564/564
(100 %)
2 diff
(99.7 %id)
BX507882   .g 1993 to 2681 1 to 689       689/690
(99 %)
1 diff
(99.9 %id)
AI452824 pooled .g 2009 to 2555 551 to 6       546/551
(99 %)
0 diff
(100 %id)
BE504694 pooled germ cell tumors .g 2014 to 2558 549 to 5       545/549
(99 %)
0 diff
(100 %id)
BU743299 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .g 2022 to 2444 440 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 422/422
(100 %)
0 diff
(100 %id)
BE242738 leukopheresis .g 2037 to 2376 1 to 340       340/340
(100 %)
1 diff
(99.8 %id)
BG167166 hypernephroma, cell line, Kidney .g 2048 to 2792 1 to 738   AAA   738/745
(99 %)
13 diff
(98.3 %id)
DB113997 thymus .g 2055 to 2635 2 to 580   capped   579/579
(100 %)
2 diff
(99.7 %id)
DA391561 thalamus .g 2075 to 2650 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
AI376906   .g 2079 to 2560 483 to 1       483/483
(100 %)
2 diff
(99.6 %id)
AI087949 pooled .g 2089 to 2555 472 to 7       466/472
(98 %)
0 diff
(100 %id)
AA384558 thyroid gland .g 2092 to 2398 1 to 308       308/308
(100 %)
1 diff
(99.7 %id)
AA909580 pooled .g 2093 to 2553 461 to 1       461/461
(100 %)
0 diff
(100 %id)
DA137924 alzheimer cortex .g 2097 to 2653 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
AU131849   .g 2108 to 2922 2 to 811   capped   810/864
(93 %)
8 diff
(99.1 %id)
DA201662 brain .g 2119 to 2745 2 to 628   capped   627/627
(100 %)
0 diff
(100 %id)
DA781871 brain .g 2119 to 2626 2 to 509   capped   508/508
(100 %)
1 diff
(99.9 %id)
DB127494 thymus .g 2119 to 2667 2 to 550   capped   549/549
(100 %)
1 diff
(99.9 %id)
CN295696 embryonic stem cells, DMSO-treated H9 cellline .g 2124 to 2433 1 to 310       310/310
(100 %)
0 diff
(100 %id)
AA688269 germinal center B cell .g 2129 to 2436 308 to 1       308/308
(100 %)
1 diff
(99.7 %id)
H96680 melanocyte .g 2146 to 2399 1 to 254       254/254
(100 %)
2 diff
(99.3 %id)
AA730861 Ewing's sarcoma .g 2157 to 2531 1 to 375       375/375
(100 %)
2 diff
(99.5 %id)
AU118102 whole embryo, mainly head .g 2159 to 2997 2 to 841   capped   840/840
(100 %)
9 diff
(99.0 %id)
BG288889 bladder, transitional cell papilloma, cell line .g 2187 to 2918 1 to 727       727/736
(98 %)
27 diff
(96.4 %id)
AW150354 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .g 2208 to 2555 350 to 3       348/350
(99 %)
0 diff
(100 %id)
BG679771 skin, squamous cell carcinoma .g 2225 to 2997 1 to 765       765/765
(100 %)
17 diff
(97.8 %id)
CB998689 Blood vessels - aorta, basilar and artery .g 2226 to 2961 1 to 749       749/769
(97 %)
20 diff
(97.4 %id)
TI_159721709   .g 2235 to 2553 58 to 376   AAA Submitted on the opposite strand 319/376
(84 %)
6 diff
(98.5 %id)
AW167208 serous papillary carcinoma, high grade, 2pooled tumors, uterus .g 2237 to 2553 334 to 18   AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 317/317
(100 %)
0 diff
(100 %id)
BX477906   .g 2241 to 2685 1 to 445       445/445
(100 %)
0 diff
(100 %id)
CB044434 colon, juvenile granulosa tumor .g 2241 to 2806 580 to 15   AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 566/566
(100 %)
0 diff
(100 %id)
DA135626 alzheimer cortex .g 2262 to 2808 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
AI679193 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .g 2275 to 2806 530 to 1       530/530
(100 %)
5 diff
(99.1 %id)
DA529462 brain .g 2279 to 2897 2 to 620   capped   619/619
(100 %)
0 diff
(100 %id)
DA486758 brain .g 2299 to 2867 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
BM145603 leukopheresis .g 2316 to 2816 507 to 4       504/511
(98 %)
0 diff
(100 %id)
AU117980 whole embryo, mainly head .g 2349 to 3137 2 to 789   capped   788/793
(99 %)
4 diff
(99.5 %id)
N29897 melanocyte .g 2379 to 2802 426 to 1       426/431
(98 %)
3 diff
(99.4 %id)
AL695015   .g 2384 to 2931 1 to 548       548/548
(100 %)
5 diff
(99.1 %id)
BU165553 eye, retinoblastoma .g 2384 to 3280 12 to 916       905/921
(98 %)
15 diff
(98.4 %id)
DR159417 human embryonic stem cells differentiated toan early endodermal cell type .g 2396 to 3156 1 to 762       762/762
(100 %)
1 diff
(99.9 %id)
CN404345 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .g 2406 to 2976 1 to 571       571/571
(100 %)
0 diff
(100 %id)
CV364898 head_neck .g 2408 to 2871 489 to 24     Submitted on the opposite strand 466/489
(95 %)
0 diff
(100 %id)
D51381   .g 2409 to 2806 396 to 1       396/396
(100 %)
2 diff
(99.5 %id)
AA485194 germinal center B cell .g 2409 to 2697 1 to 289       289/289
(100 %)
0 diff
(100 %id)
BX508217   .g 2412 to 3004 1 to 593       593/593
(100 %)
0 diff
(100 %id)
BU189670 eye, retinoblastoma .g 2483 to 3238 23 to 787       765/917
(83 %)
15 diff
(98.4 %id)
BF969376 adrenal cortex carcinoma, cell line, adrenal gland .g 2488 to 3228 1 to 742       742/752
(98 %)
8 diff
(99.0 %id)
CA407979 adipose .g 2494 to 2998 1 to 503       503/506
(99 %)
3 diff
(99.5 %id)
TI_149312353   .g 2572 to 3381 899 to 96   AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 804/931
(86 %)
12 diff
(98.8 %id)
DA829058 placenta .g 2581 to 3286 2 to 708   capped   707/712
(99 %)
9 diff
(98.8 %id)
AK093744 thymus .g 2621 to 4786 1 to 2167   tiling clone, available from FLJ, AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 2167/2167
(100 %)
6 diff
(99.8 %id)
DB108942 thymus .g 2622 to 3205 2 to 586   capped   585/585
(100 %)
2 diff
(99.7 %id)
AA091638   .g 2639 to 2812 1 to 174       174/174
(100 %)
0 diff
(100 %id)
BI753215 brain .g 2649 to 3369 1 to 719       719/719
(100 %)
4 diff
(99.5 %id)
TI_57217977   .g 2649 to 3369 36 to 754       719/754
(95 %)
6 diff
(99.3 %id)
BG611386 adenocarcinoma, Prostate .g 2698 to 3445 1 to 752       752/753
(99 %)
16 diff
(97.9 %id)
AA434050 ovarian tumor, ovary .g 2727 to 3181 1 to 454       454/454
(100 %)
3 diff
(99.4 %id)
AL047136 uterus .g 2740 to 3138 1 to 399       399/400
(99 %)
1 diff
(99.8 %id)
AA639796 colon, colon tumor RER+ .g 2856 to 3393 539 to 1       539/539
(100 %)
3 diff
(99.5 %id)
BM145777 leukopheresis .g 2863 to 3381 535 to 18   AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 518/518
(100 %)
7 diff
(98.7 %id)
BX105084 multiple sclerosis lesions .g 2918 to 3658 1 to 741       741/741
(100 %)
3 diff
(99.6 %id)
DT217453 brain .g 2918 to 3442 1 to 525       525/525
(100 %)
1 diff
(99.9 %id)
AI306583 carcinoid, lung .g 2933 to 3315 1 to 383     Submitted on the opposite strand 383/383
(100 %)
0 diff
(100 %id)
AW976843   .g 2962 to 3501 548 to 9     Submitted on the opposite strand 540/548
(98 %)
0 diff
(100 %id)
AW189454 serous papillary carcinoma, high grade, 2pooled tumors, uterus .g 2975 to 3095 121 to 1       121/121
(100 %)
0 diff
(100 %id)
CN404344 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .g 2985 to 3731 1 to 747       747/747
(100 %)
0 diff
(100 %id)
H96549 melanocyte .g 3044 to 3507 464 to 1       464/466
(99 %)
0 diff
(100 %id)
CX867489 embryonic stem .g 3256 to 4031 799 to 24   AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 776/776
(100 %)
0 diff
(100 %id)
DB368880   .g 3456 to 4031 575 to 1       575/575
(100 %)
10 diff
(98.3 %id)
DB355972 whole embryo, mainly head .g 3467 to 4031 568 to 1       568/571
(99 %)
13 diff
(97.8 %id)
DB368139   .g 3486 to 4031 549 to 1       549/549
(100 %)
10 diff
(98.2 %id)
DB356104 whole embryo, mainly head .g 3504 to 4031 525 to 1       525/573
(91 %)
5 diff
(99.2 %id)
DB373739 placenta .g 3531 to 4031 499 to 1       499/500
(99 %)
4 diff
(99.2 %id)
DB343172 thymus .g 4268 to 4786 520 to 1       520/520
(100 %)
3 diff
(99.5 %id)
AA723603 parathyroid gland, parathyroid tumor .h 1 to 477 477 to 1   tiling clone,   477/477
(100 %)
2 diff
(99.6 %id)
BG535622 lung .h 22 to 693 1 to 671       671/673
(99 %)
4 diff
(99.5 %id)
AV696792 hepatocellular carcinoma .h 40 to 678 1 to 635   tiling clone,   635/652
(97 %)
5 diff
(99.3 %id)
BG914001 anaplastic oligodendroglioma with 1p/19qloss, brain .h 579 to 1317 1 to 739 V167C S168F V169C N170Y M190P ... tiling clone,   739/759
(97 %)
8 diff
(99.0 %id)
TI_44159130   .i 1 to 748 32 to 779   tiling clone,   748/779
(96 %)
11 diff
(98.6 %id)
AJ708467 heart .i 568 to 1067 498 to 1   tiling clone, Submitted on the opposite strand 498/498
(100 %)
1 diff
(99.8 %id)
BG772133 testis .j 1 to 720 1 to 717 F50X Q141H C142A K143R I144S ... tiling clone,   718/1229
(58 %)
10 diff
(99.2 %id)
CN396946 embryonic stem cells, cell lines H1, H7, andH9 .j 27 to 669 1 to 643       643/643
(100 %)
0 diff
(100 %id)
DA857752 placenta .j 64 to 602 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
AW139157   .j 361 to 929 583 to 15   tiling clone, AAA   569/569
(100 %)
0 diff
(100 %id)
BG192219   .k 1 to 507 508 to 2 L5F F41L V42W F44Y D114G tiling clone, Submitted on the opposite strand 507/508
(99 %)
4 diff
(99.3 %id)
AI650696 pooled germ cell tumors .k 21 to 541 541 to 22   tiling clone, AAA   520/520
(100 %)
13 diff
(97.5 %id)
AI123300   .k 128 to 548 421 to 1   tiling clone,   421/421
(100 %)
1 diff
(99.8 %id)
DW448319 Liver .k 376 to 543 17 to 184       168/208
(80 %)
3 diff
(98.6 %id)
BG529306 embryonal carcinoma, testis .l 1 to 728 1 to 738 Q25K L26V S28K Q29P I30G ... tiling clone,   738/776
(95 %)
52 diff
(93.3 %id)
BU533663 mixed (pool of 40 RNAs) .l 442 to 1230 1 to 797   tiling clone,   797/803
(99 %)
18 diff
(97.8 %id)
CN295704 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .l 931 to 1621 1 to 691   tiling clone,   691/691
(100 %)
5 diff
(99.3 %id)
BX487610   .l 992 to 1524 9 to 546   tiling clone,   538/546
(98 %)
6 diff
(99.0 %id)
CN396948 embryonic stem cells, cell lines H1, H7, andH9 .m 1 to 673 4 to 676 exact tiling clone,   676/676
(100 %)
2 diff
(99.8 %id)
N87991   .m 627 to 891 1 to 264   tiling clone, AAA   264/264
(100 %)
3 diff
(98.9 %id)
AA503981 Prostate .m 684 to 1003 8 to 327   tiling clone,   320/327
(97 %)
0 diff
(100 %id)
AI440220 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .m 934 to 1279 346 to 1   tiling clone,   346/346
(100 %)
0 diff
(100 %id)
AI765815 2 pooled tumors (clear cell type), Kidney .n 1 to 519 522 to 4 exact tiling clone,   523/526
(99 %)
0 diff
(100 %id)
DB221904 trachea .o 1 to 548 2 to 549 exact tiling clone, capped   548/548
(100 %)
2 diff
(99.7 %id)
DA914358   .p 1 to 553 2 to 554 exact tiling clone, capped   553/553
(100 %)
1 diff
(99.9 %id)
AK303345 thymus .q 1 to 808 2 to 809 exact tiling clone,   809/809
(100 %)
2 diff
(99.8 %id)
DN990848 brain, whole brain .q 12 to 773 1 to 761 exact     761/761
(100 %)
5 diff
(99.4 %id)
DA849330 placenta .q 37 to 594 2 to 559 exact capped   558/558
(100 %)
0 diff
(100 %id)
CD654580 Embryonic Stem cells .q 53 to 870 12 to 830 exact     819/830
(98 %)
16 diff
(98.1 %id)
DN990484 brain, whole brain .q 56 to 766 8 to 717 exact tiling clone,   710/717
(99 %)
7 diff
(99.1 %id)
BP873327 embryonal kidney .q 83 to 677 1 to 595 exact     595/596
(99 %)
2 diff
(99.7 %id)
CN293088 embryonic stem cells, DMSO-treated H9 cellline .q 785 to 1342 1 to 559   tiling clone,   559/559
(100 %)
1 diff
(99.9 %id)
AA425315   .q 792 to 1205 1 to 414   fully sequenced, Submitted on the opposite strand 414/414
(100 %)
1 diff
(99.8 %id)
L44304   .q 834 to 1233 401 to 1       401/401
(100 %)
10 diff
(97.6 %id)
BF448246 carcinoid, lung .q 972 to 1455 1 to 484     Submitted on the opposite strand 484/484
(100 %)
1 diff
(99.8 %id)
AI869283 anaplastic oligodendroglioma, brain .q 1059 to 1583 525 to 1       525/525
(100 %)
2 diff
(99.7 %id)
AA442027   .q 1160 to 1577 418 to 1     Submitted on the opposite strand 418/418
(100 %)
0 diff
(100 %id)
AA425474   .q 1175 to 1577 403 to 1   fully sequenced, Submitted on the opposite strand 403/403
(100 %)
0 diff
(100 %id)
AI912058 carcinoid, lung .q 1191 to 1581 1 to 391     Submitted on the opposite strand 391/391
(100 %)
2 diff
(99.5 %id)
BE045586 carcinoid, lung .q 1197 to 1581 1 to 385   tiling clone, Submitted on the opposite strand 385/385
(100 %)
0 diff
(100 %id)
AW205290   .q 1242 to 1575 9 to 342     Submitted on the opposite strand 334/345
(96 %)
5 diff
(98.6 %id)
BQ358750 head_neck .q 1323 to 1643 1 to 322       322/476
(67 %)
6 diff
(98.8 %id)
CN283287 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .q 1350 to 1657 1 to 309       309/309
(100 %)
1 diff
(99.7 %id)
DA797139 brain .q 1550 to 2110 2 to 563   tiling clone, capped   562/562
(100 %)
2 diff
(99.7 %id)
BE245168 leukopheresis .q 1632 to 2033 1 to 402   tiling clone,   402/405
(99 %)
6 diff
(98.6 %id)
DA782178 brain .q 1801 to 2371 2 to 572   tiling clone, capped   571/571
(100 %)
1 diff
(99.9 %id)
DB131323 thymus .q 2328 to 2873 2 to 548   tiling clone, capped   547/547
(100 %)
1 diff
(99.9 %id)
AV657770 corresponding non cancerous liver tissue .q 2335 to 2709 1 to 379     Submitted on the opposite strand 379/380
(99 %)
17 diff
(95.6 %id)
AV657782 corresponding non cancerous liver tissue .q 2335 to 2709 1 to 381     Submitted on the opposite strand 381/382
(99 %)
17 diff
(95.6 %id)
AV657793 corresponding non cancerous liver tissue .q 2364 to 2709 1 to 349     Submitted on the opposite strand 349/350
(99 %)
14 diff
(96.0 %id)
BQ369789 placenta_normal .q 2388 to 2711 1 to 324   tiling clone,   324/324
(100 %)
7 diff
(97.9 %id)
CN277344 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .q 2554 to 2841 1 to 288       288/288
(100 %)
6 diff
(98.0 %id)
BY799353 eye .q 2608 to 3119 33 to 544       512/544
(94 %)
6 diff
(98.9 %id)
DA735818   .q 2614 to 3417 2 to 808   tiling clone, capped   807/816
(98 %)
6 diff
(99.3 %id)
CV341837 head_neck .q 2886 to 3172 292 to 6     Submitted on the opposite strand 287/316
(90 %)
0 diff
(100 %id)
CD655054 Embryonic Stem cells .q 2898 to 3657 1 to 755       755/828
(91 %)
6 diff
(99.3 %id)
CN285517 embryonic stem cells, cell lines H1, H7, andH9 .q 3022 to 3568 1 to 547       547/547
(100 %)
0 diff
(100 %id)
BU561333 testis .q 3286 to 3994 1 to 717   tiling clone,   717/813
(88 %)
11 diff
(98.7 %id)
DB368162   .q 4489 to 5049 559 to 1   tiling clone,   559/559
(100 %)
8 diff
(98.6 %id)
DB326301 brain .q 4513 to 5052 541 to 1   tiling clone,   541/541
(100 %)
2 diff
(99.7 %id)
BP421165 small intestine .r 1 to 511 1 to 510   tiling clone, Submitted on the opposite strand 510/510
(100 %)
1 diff
(99.9 %id)
N88641   .r 107 to 248 1 to 142       142/142
(100 %)
6 diff
(95.8 %id)
BP423381 small intestine .s 1 to 514 1 to 514 exact tiling clone, Submitted on the opposite strand 514/514
(100 %)
0 diff
(100 %id)
BQ083264 stomach .s 99 to 384 1 to 286       286/286
(100 %)
3 diff
(99.0 %id)
DB349768 trachea .t-u 1 to 543 544 to 1 exact tiling clone,   544/544
(100 %)
5 diff
(99.1 %id)
AL699758 human skeletal muscle .t-u 183 to 608 1 to 426       426/426
(100 %)
13 diff
(97.0 %id)
AL699773 human skeletal muscle .t-u 183 to 794 1 to 612   tiling clone,   612/612
(100 %)
3 diff
(99.6 %id)
AL700338.
matches multiple genes
human skeletal muscle .t-u 685 to 1199 1 to 514   tiling clone, also hits gene kalo 514/514
(100 %)
2 diff
(99.7 %id)
BF745965 breast .u 1 to 337 346 to 11 K2Q H4P C5S I6H L7F ... tiling clone, Submitted on the opposite strand 336/358
(93 %)
9 diff
(97.5 %id)
CA310761 Human Lung Epithelial cells, lung .va 1 to 756 774 to 19 F19X I46T tiling clone, AAA   756/765
(98 %)
3 diff
(99.7 %id)
BX410074 brain, fetal brain .vb 1 to 884 1 to 881   tiling clone,   881/881
(100 %)
14 diff
(98.5 %id)
BM505667 insulinoma, Pancreas .vb 38 to 510 1 to 476     Submitted on the opposite strand 476/476
(100 %)
8 diff
(98.4 %id)
BM509032 insulinoma, Pancreas .vb 41 to 579 546 to 8   tiling clone, Submitted on the opposite strand 539/546
(98 %)
0 diff
(100 %id)
CN295700 embryonic stem cells, DMSO-treated H9 cellline .vb 681 to 1213 9 to 542 P67T N68K Y69L G70W V71S ... tiling clone,   534/545
(97 %)
9 diff
(98.4 %id)
BF347003 anaplastic oligodendroglioma with 1p/19qloss, brain .vc 1 to 907 7 to 925 E4* tiling clone,   925/1103
(83 %)
65 diff
(94.2 %id)
CX781001 human embryonic stem cells .vd-u 1 to 793 1 to 793 exact tiling clone, Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 793/793
(100 %)
5 diff
(99.4 %id)
CX780934 human embryonic stem cells .vd-u 1957 to 2660 730 to 27   tiling clone, AAA Possibly primed on the genome, locally A rich (10/10 A in genome downstream of last aligned base) 704/705
(99 %)
0 diff
(100 %id)
R33840 placenta .ve-u 1 to 294 1 to 306   tiling clone,   306/354
(86 %)
13 diff
(96.4 %id)
CN292589 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .ve-u 53 to 603 1 to 550   tiling clone,   550/550
(100 %)
1 diff
(99.9 %id)
N52738 multiple sclerosis lesions .ve-u 551 to 787 19 to 256   tiling clone, fully sequenced,   238/256
(92 %)
3 diff
(98.9 %id)
N49956 multiple sclerosis lesions .ve-u 757 to 1300 560 to 1   tiling clone, fully sequenced,   560/560
(100 %)
27 diff
(95.2 %id)
TI_149287486   .ve-u 982 to 1868 961 to 82 exact tiling clone, AAA   880/1123
(78 %)
21 diff
(98.2 %id)
BM972792 lung .ve-u 1256 to 1868 628 to 17 exact AAA   612/612
(100 %)
1 diff
(99.9 %id)
BE673773 carcinoid, lung .ve-u 1325 to 1872 550 to 3 exact tiling clone,   548/550
(99 %)
0 diff
(100 %id)
TI_149282616   .ve-u 1372 to 1870 623 to 125 E6G V11L Q18P M41L S46F ...     499/791
(63 %)
0 diff
(100 %id)
R33841 placenta .ve-u 1510 to 1875 386 to 2 K2*     385/400
(96 %)
0 diff
(100 %id)
AI659384 Prostate .ve-u 1516 to 1871 375 to 20 exact AAA   356/356
(100 %)
7 diff
(98.1 %id)
AL705573 human skeletal muscle .vf 1 to 598 1 to 598   tiling clone,   598/598
(100 %)
0 diff
(100 %id)
CN427563 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .vf 347 to 1133 1 to 787 exact tiling clone,   787/787
(100 %)
5 diff
(99.4 %id)
DB175363 kidney, tumor tissue .vg 1 to 573 5 to 578   tiling clone, capped   577/577
(100 %)
1 diff
(99.9 %id)
DA373265 thalamus .vg 5 to 549 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA556187   .vg 5 to 564 2 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
DA777296 brain .vg 11 to 580 2 to 572   capped   571/571
(100 %)
3 diff
(99.5 %id)
DA205359 brain .vg 20 to 599 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
DA554694   .vg 20 to 566 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
DA562951 heart .vg 20 to 589 2 to 572   capped   571/571
(100 %)
4 diff
(99.3 %id)
DA690669   .vg 20 to 591 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA862726 placenta .vg 20 to 586 2 to 568   capped   567/567
(100 %)
1 diff
(99.9 %id)
DA880362 Prostate .vg 20 to 580 2 to 562   capped   561/561
(100 %)
2 diff
(99.7 %id)
DA454717 tongue, tumor tissue .vg 21 to 579 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DA501563 brain .vg 21 to 547 9 to 535   capped   527/534
(98 %)
6 diff
(98.9 %id)
DA751112   .vg 21 to 592 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA934170 Spleen .vg 21 to 605 2 to 586   capped   585/585
(100 %)
0 diff
(100 %id)
BP375405 uterus .vg 21 to 601 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
BP380273 uterus .vg 22 to 614 1 to 587       587/587
(100 %)
14 diff
(97.7 %id)
DA936780 Spleen .vg 26 to 612 2 to 588   capped   587/587
(100 %)
2 diff
(99.7 %id)
DA951316 Spleen .vg 32 to 587 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
DA277729 corpus callosum .vg 42 to 600 8 to 566   capped   559/559
(100 %)
1 diff
(99.9 %id)
DB057195 testis .vg 45 to 558 2 to 515   capped   514/514
(100 %)
0 diff
(100 %id)
DB441924 testis .vg 55 to 315 1 to 261       261/356
(73 %)
6 diff
(98.4 %id)
BP237158 coronary artery .vg 66 to 647 1 to 582       582/582
(100 %)
3 diff
(99.5 %id)
DB034440 testis .vg 66 to 632 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
BI460250 testis .vg 81 to 697 1 to 614       614/614
(100 %)
7 diff
(98.9 %id)
BM906820 ovary (pool of 3) .vg 90 to 1113 7 to 1041 S162L P176T V191G K192E C193M ... tiling clone,   1035/1102
(93 %)
50 diff
(95.5 %id)
BP359859 thalamus .vh 1 to 577 5 to 582 exact tiling clone,   582/582
(100 %)
4 diff
(99.4 %id)
DA283766 corpus callosum .vh 44 to 617 2 to 577 exact capped   576/576
(100 %)
2 diff
(99.7 %id)
BP308274 brain .vh 45 to 631 1 to 587 exact     587/587
(100 %)
0 diff
(100 %id)
DB030880 testis .vh 46 to 597 2 to 553 exact capped   552/552
(100 %)
1 diff
(99.9 %id)
DA449884 tongue, tumor tissue .vh 59 to 625 2 to 570 exact capped   569/569
(100 %)
2 diff
(99.7 %id)
DB027935 testis .vh 60 to 657 2 to 599 H37X capped   598/598
(100 %)
1 diff
(99.9 %id)
ES310023 scalp interfollicular dermis, skin .vh 64 to 643 1 to 583 exact     583/583
(100 %)
14 diff
(97.6 %id)
DB128014 thymus .vh 67 to 620 2 to 558 exact capped   557/557
(100 %)
3 diff
(99.5 %id)
CK904752 Islets of Langerhans, Pancreas .vh 114 to 695 1 to 582 exact     582/582
(100 %)
0 diff
(100 %id)
BM069780 Islets of Langerhans, Pancreas .vh 130 to 670 1 to 541 exact     541/541
(100 %)
0 diff
(100 %id)
BI461831 testis .vh 202 to 922 1 to 720 exact tiling clone,   720/720
(100 %)
9 diff
(98.8 %id)
DA159283 amygdala .vh 214 to 781 2 to 569 exact capped   568/570
(99 %)
1 diff
(99.9 %id)
DB053395 testis .vh 234 to 805 2 to 573 exact capped   572/572
(100 %)
0 diff
(100 %id)
BI461916 testis .vh 237 to 774 1 to 538 exact     538/538
(100 %)
5 diff
(99.1 %id)
BG773504 testis .vh 239 to 874 1 to 636 C2G     636/636
(100 %)
4 diff
(99.4 %id)
DB033224 testis .vh 241 to 826 2 to 588   capped   587/587
(100 %)
1 diff
(99.9 %id)
DB043126 testis .vh 241 to 797 2 to 558   capped   557/558
(99 %)
2 diff
(99.7 %id)
DB058338 testis .vh 243 to 782 2 to 541   capped   540/540
(100 %)
2 diff
(99.7 %id)
DB058290 testis .vh 245 to 764 2 to 521   capped   520/521
(99 %)
2 diff
(99.7 %id)
DB039529 testis .vh 258 to 811 2 to 555   capped   554/557
(99 %)
1 diff
(99.9 %id)
BX458457 placenta .vi 1 to 911 3 to 908 Q66H Q67S Q68R N69I Q70K ... tiling clone,   908/1024
(88 %)
42 diff
(95.9 %id)
BQ694587 adipose .vi 176 to 806 1 to 631   tiling clone,   631/631
(100 %)
1 diff
(99.9 %id)
DA868091 Prostate .vj 1 to 537 3 to 539 P26S tiling clone, capped   538/538
(100 %)
1 diff
(99.9 %id)
DA480052   .vj 5 to 551 10 to 556 exact capped   547/547
(100 %)
0 diff
(100 %id)
AU280369   .vj 29 to 592 1 to 564 I32N     564/564
(100 %)
2 diff
(99.7 %id)
DA198562 brain .vj 30 to 598 2 to 570 exact capped   569/569
(100 %)
1 diff
(99.9 %id)
BI551986 brain, hippocampus .vj 35 to 809 1 to 779 exact tiling clone,   779/932
(83 %)
10 diff
(99.0 %id)
DA342887 substantia nigra .vj 36 to 396 2 to 362 exact capped   361/361
(100 %)
0 diff
(100 %id)
DA510190 brain .vj 39 to 597 2 to 560 exact capped   559/559
(100 %)
0 diff
(100 %id)
TI_44171790   .vj 40 to 809 91 to 864 exact     774/1017
(76 %)
11 diff
(99.0 %id)
DA415557 thalamus .vj 41 to 705 2 to 666 exact capped   665/665
(100 %)
0 diff
(100 %id)
TI_44170006   .vj 41 to 837 83 to 880 exact     798/880
(90 %)
9 diff
(99.0 %id)
BI550164 brain, hippocampus .vj 42 to 837 1 to 797 exact tiling clone,   797/797
(100 %)
9 diff
(98.9 %id)
DB028211 testis .vj 42 to 581 2 to 541 exact capped   540/540
(100 %)
0 diff
(100 %id)
BP320896 placenta .vj 43 to 624 1 to 582 exact     582/582
(100 %)
0 diff
(100 %id)
DB041626 testis .vj 44 to 592 2 to 550 exact capped   549/549
(100 %)
1 diff
(99.9 %id)
DA546596   .vj 46 to 512 2 to 470 exact capped   469/469
(100 %)
4 diff
(99.2 %id)
DB464212 hippocampus .vj 47 to 506 1 to 460 P15T A35G     460/460
(100 %)
7 diff
(98.5 %id)
DB190072 lung, tumor tissue .vj 48 to 622 2 to 576 exact capped   575/575
(100 %)
0 diff
(100 %id)
AA731385 germinal center B cell .vj 112 to 546 1 to 435 exact   Submitted on the opposite strand 435/437
(99 %)
3 diff
(99.4 %id)
CD243766 testis .vk-u 1 to 783 1 to 787 exact tiling clone,   787/789
(99 %)
11 diff
(98.7 %id)
CV341119 placenta_normal .vk-u 33 to 528 1 to 504 L7I K8Q F20Y L21*     504/505
(99 %)
52 diff
(89.8 %id)
DB041110 testis .vl 1 to 564 2 to 565   tiling clone, capped   564/564
(100 %)
0 diff
(100 %id)
DB104361 thymus .vl 18 to 578 2 to 562 exact tiling clone, capped   561/561
(100 %)
0 diff
(100 %id)
DA284625 corpus callosum .vm 1 to 578 2 to 579 exact tiling clone, capped   578/578
(100 %)
1 diff
(99.9 %id)
BI523622 pooled lung and spleen .vm 14 to 163 1 to 150   tiling clone,   150/150
(100 %)
2 diff
(98.7 %id)
DB029836 testis .vn 1 to 577 2 to 578 exact tiling clone, capped   577/577
(100 %)
0 diff
(100 %id)
DB044054 testis .vo 1 to 575 2 to 576 exact tiling clone, capped   575/575
(100 %)
0 diff
(100 %id)
DA147562 amygdala .vp 1 to 574 5 to 579 S15I D16* tiling clone, capped   578/578
(100 %)
2 diff
(99.7 %id)
AA405915   .vp 17 to 242 1 to 226   tiling clone,   226/226
(100 %)
1 diff
(99.6 %id)
DB080641 testis .vq 1 to 534 2 to 535 exact tiling clone, capped   534/534
(100 %)
0 diff
(100 %id)
AW892742 nervous_normal .vr 1 to 371 13 to 383 exact tiling clone,   371/383
(96 %)
6 diff
(98.5 %id)
DB443563 testis .vs -8 to 283 1 to 292 P4R E5S S6R G7A G8A ... tiling clone,   292/315
(92 %)
6 diff
(98.1 %id)
AV659002 corresponding non cancerous liver tissue Gene TIA1andC2orf42, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
AV659693 corresponding non cancerous liver tissue Gene TIA1andC2orf42, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
BM683308 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid Gene TIA1andC2orf42, variant not shown       AAA This clone was ignored    
BM929335 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid Gene TIA1andC2orf42, variant not shown         This clone was ignored    
212 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e-u, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t-u, .u, .va, .vb, .vc, .vd-u, .ve-u, .vf, .vg, .vh, .vi, .vj, .vk-u, .vl, .vm, .vn, .vo, .vp, .vq, .vr, .vs Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI